ST Pharm Co.,Ltd. (KOSDAQ:237690)
South Korea flag South Korea · Delayed Price · Currency is KRW
163,400
-5,300 (-3.14%)
Apr 29, 2026, 3:30 PM KST

ST Pharm Revenue

In the year 2025, ST Pharm had annual revenue of 331.68B KRW with 21.16% growth. ST Pharm had revenue of 129.10B in the quarter ending December 31, 2025, with 11.55% growth.

Revenue
331.68B
Revenue Growth
+21.16%
P/S Ratio
10.60
Revenue / Employee
506.38M
Employees
655
Market Cap
3,516.37B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025331.68B57.93B21.16%
Dec 31, 2024273.75B-11.24B-3.94%
Dec 31, 2023284.99B35.67B14.31%
Dec 31, 2022249.32B83.68B50.52%
Dec 31, 2021165.64B41.53B33.47%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Biologics 4,814.00B
Celltrion 4,162.50B
ALTEOGEN 215.86B
Samsung Epis Holdings 1,510.14B
OliX Pharmaceuticals 14.67B
CLASSYS 336.82B
D&D Pharmatech 4.30B
PharmaResearch 536.29B
Revenue Rankings